Curt Freed, MD
Professor Emeritus, Medicine-Clinical Pharmacology/Toxicology

Division Head
Clinic (303) 724-6015
Print Profile
Email Profile
Featured Provider Photo

Gender: Male
Languages: English
Department, Section/Division: Medicine-Clinical Pharmacology/Toxicology
Neurology
Neurosurgery

Practice Locations

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Clinical Pharmacology
Clinical Interest for Patients
I am interested in Parkinson's Disease and Neuropharmacology.

Education & Training

Medical Schools:
  • MD, Harvard Medical School (1969)

Undergraduate Schools:
  • AB, Harvard University (MA)

Internships:
  • Los Angeles County-Harbor-UCLA Medical Center Program

Residency Program:
  • Los Angeles County-Harbor-UCLA Medical Center Program, Internal Medicine

Fellowships:
  • University of California (San Francisco) School of Medicine Program, Clinical Pharmacology

Research & Grants

Research interests for Patients:
Research in my laboratory has focused on improving treatments for Parkinson's disease. In 1988, we performed the first transplant of dopamine-producing brain cells into an American patient with Parkinson's. We have done more brain cell transplants than any other group. While the transplanted cells can replace the need to take drugs like L-DOPA, they do not stop the relentless progression of the underlying disease. In 2006, we began the search for a drug to stop Parkinson’s and have found phenylbutyrate. In animal testing, phenylbutyrate can prevent Parkinson’s from advancing. We are now testing phenylbutyrate in patients and should know in the next few years if it is able to stop the progression of Parkinson's disease in people.

Information for Referring Providers

Clinical Interests for Referring Providers
I am interested in Parkinson's Disease and Neuropharmacology.

Research Interest for Referring Providers
Research in my laboratory has focused on improving treatments for Parkinson's disease. In 1988, we performed the first transplant of dopamine-producing brain cells into an American patient with Parkinson's. We have done more brain cell transplants than any other group. While the transplanted cells can replace the need to take drugs like L-DOPA, they do not stop the relentless progression of the underlying disease. In 2006, we began the search for a drug to stop Parkinson’s and have found phenylbutyrate. In animal testing, phenylbutyrate can prevent Parkinson’s from advancing. We are now testing phenylbutyrate in patients and should know in the next few years if it is able to stop the progression of Parkinson's disease in people.
Clinic Phone: (303) 724-6015
Fax Phone: (303) 724-6012
Office Phone: (303) 724-6002